| Neha Kumar, MD | |
|
1850 Town Center Pkwy, Reston, VA 20190-3204 | |
| (703) 689-9000 | |
| Not Available |
| Full Name | Neha Kumar |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 13 Years |
| Location | 1850 Town Center Pkwy, Reston, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285925370 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 0101259809 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Reston Hospital Center | Reston, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Reston Anesthesia Associates Pc | 2567361124 | 56 |
News Archive
Sunesis Pharmaceuticals, Inc. today announced that vosaroxin, the Company's lead drug candidate, has been granted Fast Track designation by the U.S. Food and Drug Administration for the potential treatment of relapsed or refractory acute myeloid leukemia in combination with cytarabine.
A new study indicates that yoga and aerobic exercise interventions did not significantly reduce objectively measured sleep disturbances among midlife women who were experiencing hot flashes.
Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved COMETRIQ (cabozantinib) for the treatment of progressive, metastatic medullary thyroid cancer (MTC).
Elan Corporation, plc today reported its third quarter and first nine months 2011 financial results.
› Verified 8 days ago
| Entity Name | Reston Anesthesia Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932210093 PECOS PAC ID: 2567361124 Enrollment ID: O20040102000829 |
News Archive
Sunesis Pharmaceuticals, Inc. today announced that vosaroxin, the Company's lead drug candidate, has been granted Fast Track designation by the U.S. Food and Drug Administration for the potential treatment of relapsed or refractory acute myeloid leukemia in combination with cytarabine.
A new study indicates that yoga and aerobic exercise interventions did not significantly reduce objectively measured sleep disturbances among midlife women who were experiencing hot flashes.
Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved COMETRIQ (cabozantinib) for the treatment of progressive, metastatic medullary thyroid cancer (MTC).
Elan Corporation, plc today reported its third quarter and first nine months 2011 financial results.
› Verified 8 days ago
| Entity Name | Capitol Anesthesia Associates Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194106955 PECOS PAC ID: 3274848320 Enrollment ID: O20150818005376 |
News Archive
Sunesis Pharmaceuticals, Inc. today announced that vosaroxin, the Company's lead drug candidate, has been granted Fast Track designation by the U.S. Food and Drug Administration for the potential treatment of relapsed or refractory acute myeloid leukemia in combination with cytarabine.
A new study indicates that yoga and aerobic exercise interventions did not significantly reduce objectively measured sleep disturbances among midlife women who were experiencing hot flashes.
Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved COMETRIQ (cabozantinib) for the treatment of progressive, metastatic medullary thyroid cancer (MTC).
Elan Corporation, plc today reported its third quarter and first nine months 2011 financial results.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Neha Kumar, MD 607 Herndon Pkwy Ste 101, Herndon, VA 20170-5477 Ph: (703) 471-0919 | Neha Kumar, MD 1850 Town Center Pkwy, Reston, VA 20190-3204 Ph: (703) 689-9000 |
News Archive
Sunesis Pharmaceuticals, Inc. today announced that vosaroxin, the Company's lead drug candidate, has been granted Fast Track designation by the U.S. Food and Drug Administration for the potential treatment of relapsed or refractory acute myeloid leukemia in combination with cytarabine.
A new study indicates that yoga and aerobic exercise interventions did not significantly reduce objectively measured sleep disturbances among midlife women who were experiencing hot flashes.
Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved COMETRIQ (cabozantinib) for the treatment of progressive, metastatic medullary thyroid cancer (MTC).
Elan Corporation, plc today reported its third quarter and first nine months 2011 financial results.
› Verified 8 days ago
Dr. James L Torrens, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1850 Town Center Pkwy, Reston Hospital Center, Reston, VA 20190 Phone: 703-471-0919 Fax: 703-742-9081 | |
Jill Bekezela Sagonda-guerrero, MD, MPH Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1850 Town Center Pkwy, Reston, VA 20190 Phone: 703-689-9000 | |
Charles Dougherty, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1850 Town Center Pkwy, Reston, VA 20190 Phone: 703-471-0919 | |
Dr. David Lee Nadler, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1850 Town Center Pkwy, Reston, VA 20190 Phone: 703-689-9051 | |
Dr. Richard G Hetherington, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1850 Town Center Pkwy, Resotn Hospital Center, Reston, VA 20190 Phone: 703-471-0919 Fax: 703-741-9081 | |
Dr. Herbert W Fingerhut, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1850 Town Center Pkwy, Reston, VA 20190 Phone: 703-471-0919 Fax: 703-742-9081 | |
Sami Badri, M.D. Anesthesiology Medicare: May Accept Medicare Assignments Practice Location: 1850 Town Center Pkwy, Reston, VA 20190 Phone: 703-689-9000 |